Evidence map›Paper›PMID 41726396›Full record

ArticleAMIA ... Annual Symposium proceedings. AMIA Symposium2024

Machine Learning-Based Prediction of Antimicrobial Susceptibility: A Step Towards Precision Antimicrobial Stewardship.

Fatemeh Amrollahi, Fateme Nateghi Haredasht, Arin Vansomphone, Nicholas Marshall, Manoj V Maddali, Stephen P Ma, Amy Chang, Stanley C Deresinski, Mary Kane Goldstein, Sanjat Kanjilal and 5 more

Abstract read
In one paragraph

Article in AMIA ... Annual Symposium proceedings. AMIA Symposium, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Fatemeh AmrollahiStanford Center for Biomedical Informatics Research, Stanford University, Stanford, CA, USA.
Fateme Nateghi HaredashtStanford Center for Biomedical Informatics Research, Stanford University, Stanford, CA, USA.
Arin VansomphoneDepartment of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Nicholas MarshallDepartment of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Manoj V MaddaliDepartment of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Stephen P MaDepartment of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Amy ChangStanford Center for Biomedical Informatics Research, Stanford University, Stanford, CA, USA.
Stanley C DeresinskiDepartment of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Mary Kane GoldsteinDepartment of Health Policy, Stanford University School of Medicine, Stanford, CA, USA.
Sanjat KanjilalDepartment of Population Medicine at Harvard Medical School.
Richard J MedfordEast Carolina University, Greenville, North Carolina, United States.
Lauren N CooperUniversity of Texas Southwestern Medical Center, Dallas, TX, USA.
Steven M AschDepartment of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Niaz BanaeiDepartment of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Jonathan H ChenDepartment of Medicine, Stanford University School of Medicine, Stanford, CA, USA.

Funding

Measuring and Predicting Appropriate Antibiotic Use to Combat Resistant BacteriaR01AI178121 · NIAID · STANFORD UNIVERSITY · PI JONATHAN H. CHEN · 2023 to 2026
$3.1M
NIAID NIH HHS R01 AI178121
6 · The paper itself

Abstract

Antimicrobial resistance (AMR) represents an urgent global health crisis exacerbated by the frequent empirical use of broad-spectrum antibiotics. AMR is exacerbated by inherent delays in obtaining culture results and antimicrobial susceptibility data after sample collection. In this study, we developed and validated Machine Learning (ML) models using routinely collected EHR data from inpatient and outpatient encounters to predict antibiotic resistance at the time of blood, urine or respiratory bacterial culture collection. The models demonstrated robust predictive accuracy, particularly in inpatient settings where clinical data was more consistently available. Notably, the model independently identified patterns that predict resistance, similar to how a clinician would attempt to predict resistance using prior culture and susceptibility data combined with their clinical training and knowledge of microbiological resistance patterns. Integrating these predictive tools into clinical workflows could significantly enhance empirical antibiotic selection, reduce unnecessary broad-spectrum antibiotic use, and meaningfully advance antimicrobial stewardship efforts.

Indexed as

Anti-Bacterial AgentsAntimicrobial StewardshipDrug Resistance, BacterialMachine LearningElectronic Health RecordsHumansMicrobial Sensitivity TestsPrediction AlgorithmsPredictive Learning ModelsAnti-Bacterial Agents

Identifiers

PMID41726396
PMCPMC12919605

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.